{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-058213","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.169955+00:00","generated_at":"2026-06-09T00:59:59.095847+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Definitive Healthcare Q3 revenue $65.3M (+14% YoY); net loss widens to $248.7M on non-cash charges","bullets":["Revenue $65.3M, up 14% YoY from $57.4M; above high-end of guidance.","Net loss $248.7M (381% of revenue) vs $6.9M loss in Q3 2022; adjusted net income $14.6M.","Adjusted EBITDA $21.7M (33% of revenue) vs $16.4M (29%) a year ago.","Q4 guidance: revenue $65.5M-$66.5M, adjusted EPS $0.06-$0.08 on 155.6M diluted shares.","Enterprise customers grew 10% YoY to 555; customer win-backs and expansions noted."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-058213","json":"https://secwatch.observer/filing/0000950170-23-058213.json","markdown":"https://secwatch.observer/filing/0000950170-23-058213.md","text":"https://secwatch.observer/filing/0000950170-23-058213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/0000950170-23-058213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/dh-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:59:59.095847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a6c4c0a4062aae9864ee2128a364357dbfc3f45","claim":"Definitive Healthcare Corp. reported the quarter ended September 30, 2023 results: revenue $65.3 million, net income $(248.7) million.","evidence_excerpt":"EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023 Third quarter revenue grew 14% year-over-year to $65.3 million Framingham, MA (November 2, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/0000950170-23-058213-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$65.3 million"},{"label":"Net income","value":"$(248.7) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}